Your browser doesn't support javascript.
loading
Designing antifilarial drug trials using clinical trial simulators.
Walker, Martin; Hamley, Jonathan I D; Milton, Philip; Monnot, Frédéric; Pedrique, Belén; Basáñez, Maria-Gloria.
Afiliação
  • Walker M; London Centre for Neglected Tropical Disease Research, Department of Pathobiology and Population Sciences, Royal Veterinary College, University of London, Hertfordshire, AL9 7TA, UK. mwalker@rvc.ac.uk.
  • Hamley JID; London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Imperial College London, London, W2 1PG, UK. mwalker@rvc.ac.uk.
  • Milton P; London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Imperial College London, London, W2 1PG, UK.
  • Monnot F; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, W2 1PG, UK.
  • Pedrique B; London Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Imperial College London, London, W2 1PG, UK.
  • Basáñez MG; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, W2 1PG, UK.
Nat Commun ; 11(1): 2685, 2020 06 01.
Article em En | MEDLINE | ID: mdl-32483209

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncocercose / Filariose Linfática / Ensaios Clínicos como Assunto / Filaricidas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncocercose / Filariose Linfática / Ensaios Clínicos como Assunto / Filaricidas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido